Based in Burlington, N.C., LabCorp said its routine-testing demand fell by 50 percent to 55 percent at the end of the first fiscal quarter.
The company employs about 9,000 people in North Carolina and didn’t disclose how many people it will be furloughing or how long the furloughs will last. It will also freeze hiring, let go of temporary and contract workers and suspend 401(k) contributions, according to the Times-News.
Most of LabCorp’s revenue comes from conducting routine tests, such as drug-testing employees for private companies. But during the COVID-19 pandemic, demand for routine testing has fallen significantly.
The decline in routine testing led to a loss of $317 million in the first quarter, LabCorp reported.
A spokesperson for the company told the Times-News its ability to conduct COVID-19 testing won’t be affected by the furloughs.
Read the full article here.
More articles on supply chain:
COVID-19 testing update: Where the US stands now
LabCorp offering free antibody tests for anyone with provider order
Kaiser building $14M COVID-19 testing facility
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
